Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hemorrhage × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 7 Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Recurrence 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Melanoma 4 Liver Neoplasms 4 Advanced Solid Tumors 4 Solid Tumor 3 Neoplasm Metastasis 3 Biliary Tract Neoplasms 3 Triple Negative Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Tranexamic Acid 2 Misoprostol 2 carbetocin 1 Vasopressins 1 Tourniquets 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Standard of Care 1 Sensitivity Training Groups 1 Radiotherapy 1 Palliative Care 1 Oxytocin 1 Injections 1 Ethamsylate 1 Endoscopic Mucosal Resection 1 Cell- and Tissue-Based Therapy 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡